238 related articles for article (PubMed ID: 23788833)
1. A biodegradable polymeric system for peptide-protein delivery assembled with porous microspheres and nanoparticles, using an adsorption/infiltration process.
Alcalá-Alcalá S; Urbán-Morlán Z; Aguilar-Rosas I; Quintanar-Guerrero D
Int J Nanomedicine; 2013; 8():2141-51. PubMed ID: 23788833
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of a combined drug-delivery system for proteins assembled with polymeric nanoparticles and porous microspheres; characterization and protein integrity studies.
Alcalá-Alcalá S; Benítez-Cardoza CG; Lima-Muñoz EJ; Piñón-Segundo E; Quintanar-Guerrero D
Int J Pharm; 2015 Jul; 489(1-2):139-47. PubMed ID: 25936624
[TBL] [Abstract][Full Text] [Related]
3. Nanoparticle infiltration to prepare solvent-free controlled drug delivery systems.
Rodríguez-Cruz IM; Domínguez-Delgado CL; Escobar-Chávez JJ; Leyva-Gómez G; Ganem-Quintanar A; Quintanar-Guerrero D
Int J Pharm; 2009 Apr; 371(1-2):177-81. PubMed ID: 19150491
[TBL] [Abstract][Full Text] [Related]
4. Aqueous remote loading of model cationic peptides in uncapped poly(lactide-co-glycolide) microspheres for long-term controlled release.
Liang D; Frank S; Schwendeman SP
Drug Deliv Transl Res; 2024 Mar; 14(3):696-704. PubMed ID: 38038895
[TBL] [Abstract][Full Text] [Related]
5. Development of Level A in vitro-in vivo correlations for peptide loaded PLGA microspheres.
Andhariya JV; Jog R; Shen J; Choi S; Wang Y; Zou Y; Burgess DJ
J Control Release; 2019 Aug; 308():1-13. PubMed ID: 31301338
[TBL] [Abstract][Full Text] [Related]
6. The nature of peptide interactions with acid end-group PLGAs and facile aqueous-based microencapsulation of therapeutic peptides.
Sophocleous AM; Desai KG; Mazzara JM; Tong L; Cheng JX; Olsen KF; Schwendeman SP
J Control Release; 2013 Dec; 172(3):662-70. PubMed ID: 24021356
[TBL] [Abstract][Full Text] [Related]
7. Controlled release of octreotide and assessment of peptide acylation from poly(D,L-lactide-co-hydroxymethyl glycolide) compared to PLGA microspheres.
Ghassemi AH; van Steenbergen MJ; Barendregt A; Talsma H; Kok RJ; van Nostrum CF; Crommelin DJ; Hennink WE
Pharm Res; 2012 Jan; 29(1):110-20. PubMed ID: 21744173
[TBL] [Abstract][Full Text] [Related]
8. Preparation, characterization and in-vitro evaluation of sustained release protein-loaded nanoparticles based on biodegradable polymers.
Mukherjee B; Santra K; Pattnaik G; Ghosh S
Int J Nanomedicine; 2008; 3(4):487-96. PubMed ID: 19337417
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic evaluation of the glucose-induced reduction in initial burst release of octreotide acetate from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
Biomaterials; 2004 May; 25(10):1919-27. PubMed ID: 14738856
[TBL] [Abstract][Full Text] [Related]
10. Characterization of the initial burst release of a model peptide from poly(D,L-lactide-co-glycolide) microspheres.
Wang J; Wang BM; Schwendeman SP
J Control Release; 2002 Aug; 82(2-3):289-307. PubMed ID: 12175744
[TBL] [Abstract][Full Text] [Related]
11. Porous silicon oxide-PLGA composite microspheres for sustained ocular delivery of daunorubicin.
Nan K; Ma F; Hou H; Freeman WR; Sailor MJ; Cheng L
Acta Biomater; 2014 Aug; 10(8):3505-12. PubMed ID: 24793657
[TBL] [Abstract][Full Text] [Related]
12. A short term quality control tool for biodegradable microspheres.
D'Souza S; Faraj JA; Dorati R; DeLuca PP
AAPS PharmSciTech; 2014 Jun; 15(3):530-41. PubMed ID: 24519488
[TBL] [Abstract][Full Text] [Related]
13. Enhancing initial release of peptide from poly(d,l-lactide-co-glycolide) (PLGA) microspheres by addition of a porosigen and increasing drug load.
Ravivarapu HB; Lee H; DeLuca PP
Pharm Dev Technol; 2000; 5(2):287-96. PubMed ID: 10810758
[TBL] [Abstract][Full Text] [Related]
14. Polymer and microsphere blending to alter the release of a peptide from PLGA microspheres.
Ravivarapu HB; Burton K; DeLuca PP
Eur J Pharm Biopharm; 2000 Sep; 50(2):263-70. PubMed ID: 10962237
[TBL] [Abstract][Full Text] [Related]
15. Fabrication of covered porous PLGA microspheres using hydrogen peroxide for controlled drug delivery and regenerative medicine.
Bae SE; Son JS; Park K; Han DK
J Control Release; 2009 Jan; 133(1):37-43. PubMed ID: 18838089
[TBL] [Abstract][Full Text] [Related]
16. A novel in vitro release technique for peptide containing biodegradable microspheres.
Kostanski JW; DeLuca PP
AAPS PharmSciTech; 2000 Mar; 1(1):E4. PubMed ID: 14727853
[TBL] [Abstract][Full Text] [Related]
17. Effect of Manufacturing Variables and Raw Materials on the Composition-Equivalent PLGA Microspheres for 1-Month Controlled Release of Leuprolide.
Zhou J; Walker J; Ackermann R; Olsen K; Hong JKY; Wang Y; Schwendeman SP
Mol Pharm; 2020 May; 17(5):1502-1515. PubMed ID: 32074448
[TBL] [Abstract][Full Text] [Related]
18. NGF release from poly(D,L-lactide-co-glycolide) microspheres. Effect of some formulation parameters on encapsulated NGF stability.
Péan JM; Venier-Julienne MC; Boury F; Menei P; Denizot B; Benoit JP
J Control Release; 1998 Dec; 56(1-3):175-87. PubMed ID: 9801441
[TBL] [Abstract][Full Text] [Related]
19. Reverse Engineering the 1-Month Lupron Depot®.
Zhou J; Hirota K; Ackermann R; Walker J; Wang Y; Choi S; Schwendeman A; Schwendeman SP
AAPS J; 2018 Oct; 20(6):105. PubMed ID: 30280294
[TBL] [Abstract][Full Text] [Related]
20. Assessment of protein release kinetics, stability and protein polymer interaction of lysozyme encapsulated poly(D,L-lactide-co-glycolide) microspheres.
Jiang G; Woo BH; Kang F; Singh J; DeLuca PP
J Control Release; 2002 Feb; 79(1-3):137-45. PubMed ID: 11853925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
